Clinical Trial Update: Carnosine and Cognitive Training in Schizophrenia [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial evaluating the combination of carnosine and cognitive training in schizophrenia has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Carnosine (carnosine)

Snippet

Sponsor: Abraham Reichenberg | Conditions: Schizophrenia | Phase 2, Phase 3 | Status: COMPLETED